A widely used antidepressant drug could help the immune system fight cancer, according to UCLA research. The newly reported study showed that selective serotonin reuptake inhibitors (SSRIs) significantly enhanced the ability of T cells to fight cancer and suppressed tumor growth across a range of cancer types in both mouse and human tumor models. The work identified the serotonin transporter (SERT) as a promising immune checkpoint target. “It tu…